News & Updates
Filter by Specialty:
Ondansetron shows potential in irritable bowel syndrome with diarrhoea
27 Mar 2023
A study on titrated ondansetron for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) has fallen short of meeting the endpoint due to being underpowered. However, when data from this study and two others were pooled in a meta-analysis, ondansetron appears to yield significant improvements in the composite endpoint set by the Food and Drug Administration (FDA), namely stool consistency and urgency.
Ondansetron shows potential in irritable bowel syndrome with diarrhoea
27 Mar 2023
Perfluorohexyloctane eye drops for dry eye disease impresses in phase III trial
25 Mar 2023
The novel NOV03 ophthalmic drop consisting of perfluorohexyloctane appears to help reduce both signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD), as shown in the results of the phase III MOJAVE study.
